TV 목록 보기
증권
지난 주요뉴스 한국경제TV에서 선정한 지난 주요뉴스 뉴스썸 한국경제TV 웹사이트에서 접속자들이 많이 본 뉴스 한국경제TV 기사만 onoff
[PRNewswire] 이노비오, VGX-3100 품질 및 비임상 데이터의 유럽의약청 승인 획득 2019-05-07 00:07:38
Inc.) Inovio Receives European Medicines Agency Certification For Quality and Non-Clinical Data for Its Phase 3 Product, VGX-3100 PLYMOUTH MEETING, Pennsylvania, May 6, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced that its lead Phase 3 product candidate, VGX-3100,...
[PRNewswire] 이노비오, MEDI0457의 2상 실험에서 세 번째 암 적용 단계 달성 2019-04-09 10:38:56
2 Development PLYMOUTH MEETING, Pennsylvania, April 8, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that it achieved a third indication milestone from AstraZeneca resulting from dosing a patient in a Phase 2 combination trial evaluating MEDI0457 (formerly called...
[PRNewswire] 웨스트社, 신규 지사 통해 한국 내 영향력 확대 2019-04-04 10:52:49
Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia. West's 2018 net sales of $1.7 billion reflect the daily use of approximately 112 million of its components and devices, which are designed to improve the delivery of healthcare...
[PRNewswire] 이노비오, 미국암연구협회의 연례 회의에서 임상 데이터 발표 2019-04-04 10:27:12
in Pilot Clinical Study -- Clinical Data Presented at Annual Meeting of American Association for Cancer Research PLYMOUTH MEETING, Pennsylvania, April 3, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced its novel therapy INO-3106 against the human papilloma virus type 6...
[PRNewswire] 이노비오, AACR에서 임상 전 연구결과 발표 2019-04-03 09:56:17
Engagers (dBiTEs) at AACR -- Data demonstrates tumor-clearing ability of Inovio's dBiTE technology in preclinical cancer model PLYMOUTH MEETING, Pennsylvania, April 2, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today the company's novel DNA-Encoded Bi-specific...
[PRNewswire] Two Sigma Appoints Kenny Lam To Oversee Growth In Asia-Pacific 2019-04-03 09:43:59
Pennsylvania's Wharton School. Mr. Lam will be based in Hong Kong and starts with the company on April 8, 2019. About Two Sigma Two Sigma's mission is to find value in the world's data. Its clients in investment management, insurance, securities, private investments and venture capital...
[PRNewswire] 이노비오, 임상시험에서 예정보다 빠른 환자 등록 완료 2019-04-02 09:51:31
in Combination with Regeneron's PD-1 Inhibitor PLYMOUTH MEETING, Pennsylvania, April 1, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that its Phase 1/2 immuno-oncology trial in patients with newly diagnosed glioblastoma (GBM) has completed its enrollment three...
[PRNewswire] 이노비오의 피부 주입 에볼라 백신, 100% 면역원성 구현 2019-03-22 09:57:59
University of Pennsylvania, Parker Institute for Cancer Immunotherapy, CEPI, DARPA, GeneOne Life Science, Plumbline Life Sciences, NIH, HIV Vaccines Trial Network, National Cancer Institute, Walter Reed Army Institute of Research, Drexel University, and Laval University. For more information, visit...
[PRNewswire] Victaulic Offers an Off-The-Truck Flexible Solution for Cold 2019-03-20 13:14:47
solution reduces the risk of condensation impeding the system (EASTON, Pennsylvania, March 19, 2019 PRNewswire=연합뉴스) Victaulic(R) [https://www.victaulic.com/ ], the world's leading manufacturer of mechanical pipe-joining systems, announced the launch of its VicFlex [https://www.vicflex.com/...
[PRNewswire] 이노비오, REVEAL 2 전 세계 임상 3상 연구 착수 2019-03-05 09:57:24
study initiation announcement made during the International HPV Awareness Day PLYMOUTH MEETING, Pennsylvania, March 4, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced the initiation and opening of sites to enroll the second portion of the company's Phase 3 program...
TV 목록 보기
증권
